Atonarp
分子レベルで世界を解きあかす
Tokyo, Japan · Founded 2009 · $83.0M raised
- Headquarters
- Tokyo
- Founded
- 2009
- Business Model
- B2B
- Website
- atonarp.com
- Total Funding
- $83.0M
- Last Round
- $33.0M Series CMay 2021
- Rounds
- 2
About
Mass spec and optical spec systems for molecular analysis in clinical diagnostics
Summary
Atonarp is a Diagnostics company based in Tokyo, Japan, founded in 2009. It has raised $83.0M in total across 2 rounds, most recently a $33.0M Series C round in May 2021. Investors include Celesta Capital and SBI Investment.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
May 2021
Sign up to see all 2 rounds
Series C through Series D — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies

Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...

Develops an automated benchtop blood-testing analyzer that delivers lab-accurate routine blood te...

Develops blood-based protein diagnostics for earlier, more accurate diagnosis and monitoring of A...
Develops MicroOrganoSphere ex vivo tumor models and AI analytics to guide precision oncology and ...
Self-driving cars.
Emission free, always on power from advanced fission power plants.
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/atonarp"><img src="https://indexed.vc/api/badge/company/atonarp" alt="Atonarp on Indexed.vc" width="260" height="76" /></a>
